CORPORATE FINANCE RESEARCH SALES LEGAL & COMPLIANCE EN LIFE SCIENCES INTRO CORPORATE FINANCE SECTOR AQUACULTURE COMMERCIAL REAL ESTATE FINANCIAL INSTITUTIONS OIL & GAS INFRASTRUCTURE & UTILITIES LIFE SCIENCES PRIVATE EQUITY RENEWABLES SHIPPING TELECOMMUNICATIONS, MEDIA AND TECHNOLOGY PRODUCT DEBT CAPITAL MARKET EQUITY CAPITAL MARKET MERGERS AND ACQUISITIONS RESTRUCTURING SALE & LEASEBACK Arctic Securities — Corporate Finance — Life Sciences LIFE SCIENCES The Norwegian life sciences industry is evolving rapidly. Having previously operated in the shadow of successful company clusters in Sweden and Denmark, Norwegian life sciences companies are now increasingly being recognized in their own right and attracting attention and interest from all over the world. Continued research and development (R&D) by research centres in hospitals and universities in Norway is expected to contribute to the further development of the life sciences industry over the next decade. We expect growth in all relevant segments and particularly within oncology. Arctic Securities has dedicated significant resources to the sector, and has been involved in most of the Norwegian transactions within the life sciences sector over the last years. We combine in-depth medical knowledge with capital markets competence across all product areas. COMPANY CAREER MANAGEMENT BOARD OF DIRECTORS ARCTIC GROUP INTERACTIVE HOMEOFFICE OFFERINGS COMPLIANCE LICENSES TERMS AND POLICIES DISCLAIMER RESEARCH DISCLAIMER WEB CLIENT SUPPORT ARCTIC ONLINE CORPORATE ACCESS LEI REGISTRATION SETTLEMENT VPS INVESTOR SERVICES FOLLOW US IN SOCIAL MEDIA: RSS LINKEDIN TWITTER FACEBOOK INSTAGRAM YOUTUBE © Arctic Securities AS Cookies ; Cookie SettingsAccept all cookies